Association of Post-procedural Glucose with Clinical Outcomes After Endovascular Therapy for Large Vessel Occlusion
Open Access
- 12 December 2025
- journal article
- research article
- Published by Springer Nature in Neurology and Therapy
- Vol. 15 (1) , 367-381
Abstract
Introduction Glucose at admission predicted poor outcome for patients with acute large vessel occlusion (LVO) undergoing endovascular therapy (EVT). Prior studies ignored continuous glucose monitoring after EVT. Therefore, we aim to evaluate the association between post-procedural glucose levels and outcomes in real-world settings. Methods This study was based on a multicenter cohort. Patients with LVO who underwent EVT within 24 h of symptom onset were enrolled. We analyzed post-procedural blood glucose based on preprandial blood glucose levels within 48 h after EVT recognizing disrupted normal dietary patterns and circadian rhythms due to severe symptoms of LVO. Primary clinical outcome was functional independence (90-day modified Rankin scale score 0–2). We evaluated the association between post-procedural glucose and functional independence using logistic regression and assessed whether stroke severity modified this association. Results A total of 693 patients were included. Multivariate logistic regression analysis showed that decreased average post-procedural glucose per unit was significantly related to functional independence (adjusted odds ratio [aOR]: 0.75, 95% confidence interval [CI] 0.68–0.83, P < 0.001). Hyperglycemia was defined as any preprandial blood glucose within 48 h after EVT ≥ 7.6 mmol/L based on the restricted cubic spline regression model. The hyperglycemia group was also significantly associated with functional independence (aOR: 0.54, 95% CI 0.36–0.82, P = 0.003), symptomatic intracranial hemorrhage (aOR: 2.16, 95% CI 1.08–4.34, P < 0.001), and 90-day mortality (aOR: 1.71, 95% CI 1.04–2.79, P = 0.033). Subgroup analysis specifically in individuals with severe stroke (defined as National Institutes of Health Stroke Scale [NIHSS] ≥ 15) showed that hyperglycemia was a risk factor for low functional independence. Conclusion Increased post-procedural glucose is associated with poor functional outcome after endovascular treatment and an increased risk of symptomatic intracranial hemorrhage after endovascular treatment, especially for those with more severe strokes.Keywords
Funding Information
- The Chongqing Technology Innovation and Application Development Project (CSTB2022TIAD-KPX0160)
- the Science and Technology Research Program of Chongqing Education Commission of China (KJQN202300402)
- the Joint project of Chongqing Health Commission and Science and Technology Bureau (Tao Xu)
This publication has 35 references indexed in Scilit:
- Favorable Cerebral Collateral Cascades Improve Futile Recanalization by Reducing Ischemic Core Volume in Acute Ischemic Stroke Patients Undergoing Endovascular TreatmentTranslational Stroke Research, 2025
- Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic StrokeJAMA, 2025
- Evolution of glucose levels in patients with anterior circulation acute ischemic stroke treated with endovascular therapy using continuous glucose monitoringJournal of Stroke and Cerebrovascular Diseases, 2024
- Admission hyperglycemia effect on symptomatic intracranial hemorrhage in tenecteplase versus alteplase before large vessel occlusion stroke thrombectomyJournal of Neurology, 2024
- Hyperglycemia Aggravates Blood–Brain Barrier Disruption Following Diffuse Axonal Injury by Increasing the Levels of Inflammatory Mediators through the PPARγ/Caveolin-1/TLR4 PathwayInflammation, 2022
- Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic StrokeJAMA, 2019
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Increased oxidative stress during hyperglycemic cerebral ischemiaNeurochemistry International, 2007
- Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK)The Lancet Neurology, 2007
- Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinasesDiabetologia, 2006